- DICI (Dojin Institute of Cancer Immunology)
Announcement of AMED adoption in joint research with the National Cancer Center Japan
The joint research conducted by our company with the National Cancer Center, Tokyo University of Agriculture and Technology, and the University of Tokyo was adopted as AMED’s “Next Generation Cancer Medical Creation Research Project” in 2020
https://www.amed.go.jp/koubo/01/03/0103C_00018.html